346 related articles for article (PubMed ID: 4261214)
1. [Round-table discussion on immunosuppressive agents in ophthalmology].
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):75-100. PubMed ID: 4261214
[No Abstract] [Full Text] [Related]
2. [Immunodepressors in ophthalmology].
Bonnet M
Annee Ther Clin Ophtalmol; 1971; 22():117-55. PubMed ID: 4356770
[No Abstract] [Full Text] [Related]
3. [Immunosuppressive therapy in ophthalmology].
Meyer HJ
Arzneimittelforschung; 1970 Oct; 20(10):1471-3. PubMed ID: 4921169
[No Abstract] [Full Text] [Related]
4. [Immunosuppressive therapy].
Melli G
Recenti Prog Med; 1970 Jan; 48(1):1-18. PubMed ID: 4910156
[No Abstract] [Full Text] [Related]
5. [Immunosuppression].
Amiel JL
Minerva Med; 1970 Jul; 61(55):3022-7. PubMed ID: 5427676
[No Abstract] [Full Text] [Related]
6. [Current status of immunosuppression].
Kaspar F
Dtsch Med J; 1968 Apr; 19(7):211-3. PubMed ID: 4180292
[No Abstract] [Full Text] [Related]
7. [The place of immunology in ophthalmology (author's transl)].
Zirm M; Schmut O
Wien Klin Wochenschr; 1974 Apr; 86(8):205-9. PubMed ID: 4601166
[No Abstract] [Full Text] [Related]
8. [Immunosuppressive treatment and its side effects].
Scheiffarth F
Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064
[No Abstract] [Full Text] [Related]
9. [Aspects of treatment with immunosuppressive agents in ophthalmology].
Micşa MV; Weinberg J; Ciocan I; Zapolschi D; Popovici S
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):233-5. PubMed ID: 6460300
[No Abstract] [Full Text] [Related]
10. [What is certain in the treatment with immunosuppressive agents?].
Malchow H
Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
[No Abstract] [Full Text] [Related]
11. [Possibilities and limitations of immunosuppressive treatment].
Stobbe H
Allerg Immunol (Leipz); 1973; 19(2-4):363-79. PubMed ID: 4281637
[No Abstract] [Full Text] [Related]
12. Ocular immune responses. Summary statement.
Silverstein AM
Mod Probl Ophthalmol; 1976; 16():328-33. PubMed ID: 765786
[No Abstract] [Full Text] [Related]
13. Complications of immunosuppression.
Penn I
Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243
[No Abstract] [Full Text] [Related]
14. [Immunosuppressive therapy].
Fink U
Med Klin; 1969 Jun; 64(23):1069-72. PubMed ID: 4185573
[No Abstract] [Full Text] [Related]
15. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
Waltman SR; Faulkner HW; Burde RM
Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
[No Abstract] [Full Text] [Related]
16. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
17. [Production and application of antilymphocyte sera].
Pichlmayr R
Med Klin; 1969; 64(26):1187-90. PubMed ID: 5807322
[No Abstract] [Full Text] [Related]
18. Immunosuppression and its complications.
Woodruff M
Proc R Soc Med; 1969 Apr; 62(4):411-6. PubMed ID: 4897833
[No Abstract] [Full Text] [Related]
19. [Bases of immunosuppression and immunostimulation including their side effects in immunopathological diseases].
Deicher H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():773-82. PubMed ID: 612054
[No Abstract] [Full Text] [Related]
20. [Immune tolerance and antilymphocyte sera].
Kaden J
Z Arztl Fortbild (Jena); 1971 May; 65(9-10):522-8. PubMed ID: 5000438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
